SIX Swiss Exchange · Healthcare
Invest in Alcon stock from India
Indian and foreign residents can buy Alcon (ALC) shares directly through Paasa.
By Paasa · Updated
Alcon at a glance
- Price
- CHF 53.98-CHF 0.42 (0.77%)
- Market cap
- CHF 26.31B
- Day range
- CHF 53.96 – CHF 54.90
- P/E
- 49.81
- Dividend yield
- 0.55%
- Volume
- 858.70K
- 1 month
- -6.77%
- 6 months
- -9.12%
- YTD
- -14.70%
- 1 year
- -8.91%
- 5 years
- -29.01%
Alcon statements, FY2021–FY2025
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $10.9B | $9.9B | $9.5B | $8.7B | $8.3B |
| Gross profit | $6.0B | $5.5B | $5.2B | $4.7B | $4.7B |
| Operating income | $1.4B | $1.4B | $1.0B | $672.0M | $580.0M |
| Net income | $1.0B | $1.0B | $974.0M | $335.0M | $376.0M |
| Earnings per share | $2.08 | $2.06 | $1.96 | $0.68 | $0.77 |
| EBITDA | $2.8B | $2.7B | $2.2B | $1.7B | $1.8B |
| Total assets | $31.5B | $30.3B | $29.6B | $29.2B | $28.0B |
| Total debt | $5.7B | $5.1B | $5.1B | $5.1B | $4.5B |
| Cash and short-term investments | $1.6B | $1.8B | $1.1B | $980.0M | $1.6B |
| Shareholders' equity | $22.0B | $21.6B | $20.6B | $19.7B | $19.3B |
| Operating cash flow | $2.4B | $2.1B | $1.4B | $1.2B | $1.3B |
| Free cash flow | $1.8B | $1.4B | $537.0M | $472.0M | $165.0M |
| Capital expenditure | −$568.8M | −$670.0M | −$851.0M | −$745.0M | −$1.2B |
Fiscal years as reported, the latest ending 31 Dec 2025. Figures in USD; a dash means the provider reported nothing for that line.
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| Lonza | LONN.SW | CHF 575.20 | CHF 40.17B |
| Sandoz | SDZ.SW | CHF 70.86 | CHF 30.66B |
| Zimmer Biomet | ZBH.SW | CHF 77.50 | CHF 14.99B |
| Sonova | SOON.SW | CHF 251.60 | CHF 14.95B |
| Straumann | STMN.SW | CHF 91.54 | CHF 14.60B |
| Ypsomed | YPSN.SW | CHF 366.00 | CHF 4.81B |
| Tecan | TECN.SW | CHF 234.40 | CHF 2.97B |
| SKAN | SKAN.SW | CHF 70.70 | CHF 1.59B |
Peers as grouped by the data provider. This is not an investment recommendation.
Analyst price targets
- Low
- —
- High
- —
- Median
- —
- Consensus
- —
Ratings: 14 buy · 7 hold · 2 sell. Consensus: Buy.
Published sell-side 12-month targets in CHF, aggregated by the data provider. They are not Paasa's view and not a forecast.
How to invest in Alcon from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to CHF when you buy.
Step 3
Search ALC and buy
Find Alcon by name or by its ticker, ALC, and place your order.
Why invest in Alcon from India
What Alcon does
Alcon Inc. is a global eye care enterprise dedicated to the research, development, manufacturing, and distribution of a comprehensive range of vision products for both eye care professionals and their patients worldwide. The company operates through two primary divisions. Alcon operates in the Medical - Specialties industry within the Healthcare sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy Alcon stock from India?
Yes. Indian residents and NRIs can buy Alcon (ALC) shares directly through Paasa. Alcon is listed on the SIX Swiss Exchange, in the Medical - Specialties industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
What tax do I pay in India when I sell Alcon shares?
In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the CHF/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.